AZD-9291 Mesylate; Osimertinib Mesylate CAS 1421373-66-1

Pwodwi deskripsyon

Non pwodwi: AZD-9291 Mesylate; Osimertinib Mesylate CAS NO: 1421373-66-1

 

 

Synonyms:

AZD-9291 (Mesylate);

N-(2-((2-(dimethylamino) etilik) (méthyle) amine) -4-methoxy-5-((4-(1-méthyle-1H-indol-3-yl) pyrimidin-2-yl) amine) phenyl) acrylamide methanesulfonate;

N-[2-[[2-(Dimethylamino) etilik] methylamino] -4-methoxy-5-[[4-(1-méthyle-1H-indol-3-yl) -2-pyrimidinyl] amine] phenyl] -2-propenamide methanesulfonate;

 

 

Chimik & pwopriyete fizik

Aparans: jon solid.

Épreuves: ≥ 99,5%

 

 

Sou Novanm 13, 2015, FDA a US te apwouve lis la nan grenn osimertinib oral, yon nouvo Dwog nan AstraZeneca nan UK a, anba non an komes nan tagrisso. Li itilize pou tretman pou avanse pou pi piti pasyan kanse nan poumon ak liv chimik mutation nan epidermal fakte kwasans récepteurs (EGFR) pwosesis T790M oswa rezistans nan lot EGFR inhibiteurs. Li nesese yo detekte si T790M mutation rive nan pasyan ki gen EGFR inibite osimoltinib anvan itilize klinik. Selman pasyan ki gen kanse ki pa ti selil poumon ak mutation T790M ka resevwa tretman vize ak ocimotinib.

 

 

Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D objektif selman. Sepandan, responsablite final la manti selman avek achte a.

 

Baj popilè: azd-9291 mesylate; osimertinib mesylate cas 1421373-66-1, manifaktire, founise, faktori, achte, nan Stock

• On: N1 - [2 - (Dimetilamino) etil] -5-metoksi-N1-methyl-N4- [4- (1-methyl-1H-indol-3-il) - 2 - pirimidinyl] -1, {14}}, 4-benzèntriamin CAS 14 2 137 2 - 66-8
• Pwochen: Osimertinib CAS 1421373-65-0